US university confers doctorate on Dr Kaup Mohamed

[email protected] (CD Network)
June 18, 2016

Dubai, Jun 18: Dr Kaup Mohamed, the Dean and Director of the London American City College, who hails from Kaup in Udupi District, has been conferred with a Doctorate in Business Administration from the Apollos University, California, USA.

kaup 2 copy

The Board of the Apollos University in California and the Board of the Euro College and several other dignatories, faculty members, staff members, students and the Guests congratulated Dr Kaup on receiving his Doctorate.

Dr. Kaup was conferred with the Doctorate in Business Administration from Apollos University, USA for his thesis titled "A Critical Evaluation of Skills of Today's Students in Leading a Managing a Business Enterprise in the UAE". The dissertation committee was chaired by Dr. Paul Eidson from Apollos University, California, USA.

The leadership programs are becoming more remarkable and important in the Colleges and Universities which enables the students to become a good and efficient leader for industrial enterprises. The student community is not taking studies seriously. They neglect their studies and are not interested in developing their skills successfully. In this research, the student's capabilities are checked as to whether a student in the current environment has learnt the requisite skills required for leading and managing a business enterprise.

This research emphasised on analyzing the skills obtained during their learning environment in the Colleges. This research also reflected on the leadership qualities and analyzed whether the students are also using and applying their 5 performance objectives.

This research investigated the learning skills of the students and also compared the entrepreneurship skills and behavior of working and non-working students in managing business environment. This research also investigated the capability of current students in accepting risk & challenges in managing a business enterprise. The core intension behind the research was to evaluate the skills of today's students in leading and managing a business enterprise in the UAE. The questionnaire covered 13 sections namely (A) Entrepreneurial Skills (B) Ethical Responsibility (C) Innovative skills (D) Leadership skills (E) Learning Skills (F) Oral communication and presentation skills (G) Planning and Organizing skills (H) Risk management skills and responding to change (I) Self Management skills (J) Team work skills (K) Setting goals and time management (L) Negotiation and decision making and (M) Attitude and behavior skills.

Dr. Kaup has contributed and researched immensely on knowledge management with a teaching experience of more than 25 years and Deanship for more than 18 years. Dr. Kaup has spent his whole life in academics, education and research. Dr. Kaup has won several awards in the field of management research and development, project research and development and is an excellent academician with immense research oriented knowledge.

Dr. Kaup Mohamed is the only one person in Beary community currently holding 9 Doctorates in various fields of study from India and abroad. Dr. Kaup has published several scholarly research articles and a thesis in strategic Management area and other allied areas of management.

Dr. Kaup has visited several countries namely USA, UK, Netherlands, Belgium, Denmark, France, Germany, Austria, Macedonia, Singapore, Thailand, Spain, Russia, India, Australia, New Zealand, Srilanka, Turkey, etc. for delivering his lectures.

Dr. Kaup has won several national and international awards. His current area of research interest is in Business Strategies, Operations & Production Management, Quality Management, Consumer Protection Law, Creative Problem Solving – A Total Systems Approach, Decision Making, Organizational Behavior, Human Resource Management, Business Project Management, Marketing, Strategies for Success, etc. His research paper on “Customer Relationship Management that aids in customer-centric processes” was published in “The Observer of Management Education” Journal. His latest publications including "Development of New Concepts and Purposes add value to CRM" etc. are featured in the International Journal of Management Research and Review, International Journal of Research in Commerce, Economics and Management in the area of strategic management, etc.

kaup 1 copy

kaup 3 copy

Comments

Rafik sathikal
 - 
Saturday, 18 Jun 2016

Masha allah ..great achievement

Ahamad Gulam Beary
 - 
Saturday, 18 Jun 2016

Great achievement....Congrats

Thanzeel
 - 
Saturday, 18 Jun 2016

CONGRATULATIONS SIR!

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com news network
May 19,2020

Udupi, May 19: Within minutes after health and family welfare department announced four fresh covid-19 cases in Udupi district, a girl who had come from central part of Karnataka tested positive for the coronavirus thereby taking the count of cases detected after last evening to five. 

With this the total number of confirmed covid-19 cases in the district rose to 16. Three among them have recovered. One patient died last week. There are 12 active cases. 

According to sources, the 17-year-old girl from Chitradurga had visited KMC hospital in Manipal for cancer treatment on May 16. 

Her throat swabs were sent for corona testing on the following day. Today she obtained a positive report. Hence, she was shifted to Dr TMA Pai Covid hospital.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 16,2020

University of Oxford researchers have claimed that a cheap and widely available drug called dexamethasone can help save the lives of patients who are seriously ill with coronavirus.

Scientists working on the Recovery Trial found the drug could help patients on ventilators and oxygen, but had no effect on those who did not need help breathing.

“Based on these results, one death would be prevented by treatment of around eight ventilated patients or around 25 patients requiring oxygen alone,” researchers said in a statement.

Matt Hancock, the health secretary, tweeted: “This global first exemplifies the power of science.”

“I’m absolutely delighted that today we can announce the first successful clinical trial for a treatment for Covid-19,” Mr Hancock said.

Recovery Trial experts said a randomised group of 2,104 patients was given 6mg of dexamethasone per day for 10 days, while another group of 4,321 were given normal treatment.

Dexamethasone reduced deaths by one-fifth in patients on oxygen feeds and by one-third in those who needed a ventilator to breathe, preliminary results showed.

Mr Hancock added: “This is a huge step forward and it’s because we’ve backed the science.”

Martin Landray, professor of medicine and epidemiology at the Nuffield Department of Population Health, University of Oxford, and one of the trial’s chief investigators, said in a statement: “These preliminary results from the Recovery Trial are very clear – dexamethasone reduces the risk of death among patients with severe respiratory complications.

“Covid-19 is a global disease – it is fantastic that the first treatment demonstrated to reduce mortality is one that is instantly available and affordable worldwide.”

Comments

kushal kumar
 - 
Thursday, 18 Jun 2020

Trials  of  drug  dexamethasone   in  Covid-19  cases   have  brought  success  in  saving  lives  ,  claim  Oxford  University  scientists  on  16 June  2020. 

              According  to  news  reports  on  16 June  , 2020  ,   Oxford  University  Scientists  have  conducted  trials  on  anti-inflammatory  steroid  Dexamethasone   in  Covid-19  cases.  Results  released  by  the   Oxford  University    on  16  June  2020  say  that  the   low-cost  and  easily  available  drug  saves  the  people  seriously  infected  by   Coronavirus  ,  cuts  the  death  risk  by  a  third  for  those  on  ventilators  and  by  a  fifth  for  those  on  oxygen.  The  commentary   on  the  drug   reads  like  this  :-

“  This  is  a  tremendous  news  today  from  the  recovery  trial  showing  that  dexamethasone   is  the  first  drug  to  reduce  mortality  from  Covid-19.  It  is  particularly  exciting  as  this  is  an  inexpensive  widely  available  medicine.  This  is  a  ground  breaking  development  in  our  fight  against  the  disease  and  the  speed  at  which  researchers  have  progressed  finding  an  effective  treatment  ,  is  truly  remarkable.  It  shows  importance  of  doing  high  quality  clinical  trials  and  basing  decisions  as  the  results  of  those  trials”. 

               Covid-19  has  taken  into  its  grip   the  entire  world  during  first  half  of  the  year  2020  ,  infecting   lacs  and  killing  also  lacs  of   its  patients.  In  the  absence  of  an  effective  drug  or  vaccine  ,  people  had  no  choice  other  than   to   look   up   to  the  heavens  or   scientists  to  come  with  some  cure.  And  the  drug  described  here  is  the  first  one  to  respond  to  the  prayer   of  the  global  community  ,  it  seems.     As  regards  a  vaccine  ,   only  few  are  claiming  that  it  can  come  by  the  end  of  the  present  year  2020.  Rather   ,  some  are  of  the  view  that  it  may  take  a  larger  part  of  the  year  2021  and   could   even  go    to  mid-2022.   Whatever  that  scenario  about  prospect  of  arrival  of  vaccine  to  treat  Covid-19  may  be   ,  the  news  that  was  broken   on  16  June  2020   by   the  Oxford  University   scientists   in  relation  to   drug  dexamethasone   would  have  sent  a  wave  of   strength  and  hope   among   people  world-wide.  And  this  Vedic  astrology  writer  was  spirited  for  another  reason  as   well   -  a  prediction  of   when  some  relief   by  way  of  drug  to  fight  Covid-19   may  appear  ,   having  come  accurate  in   the   claim  announced  by  Oxford  University   on  16 June  2020.  This  writer  had  ,   based   on  interpretation  and  application   of  Vedic  astrology  ,   contributed  in  early  April  ,  2020   an  opinion  piece     - “  Some  searchlight  on  way  out  of  Covid-19  presently  tormenting  mankind” -   to  a  number  of   newspapers.  It  was  also  contributed  on  11  April  ,  2020   using  the  ‘ comments’   column  of  article  -‘ Heard  Charles  took   Ayurveda  treatment-based  Ayush  drugs  for   Covid-19’  -   at   theprint.in/india/looking-at-evidence-based-ayush-medicines-to-treat-covid-19-minister-shripad-naik/393407/.   The  text  in  the  opinion  piece  related  to  the  claim  of  success  announced  by  Oxford  University  scientists  on  16 June  ,  2020  ,  reads  like  this  :- 

“  So  reading  in  between  the  lines  ,  it  can  be  said  that  some  effective  drug   or  remedy  can  arrive  by   mid   or  towards   the  last  week  of  June  2020   to   provide  some  relief  during  July  to  September  2020 ,  to  some  good  extent”.

The  point  this  writer  wants  to  share  with  readers  world-wide  is  that   yes  ,  a  drug   envisaged  in  the  aforesaid  prediction  has  appeared  on  the  horizon  in  the  claim  announcement  of  Oxord  University  scientists  on  16  June ,  2020. 

Bio  :-

 

Kushal  kumar  ,

202-GH28  ,  Mansarovar   Apartments  ,

Sector  20  ,  Panchkula-134116  ,  Haryana,

India.

Note  :-  This  writer’s    significant  predictive  work  covering   2020   about   the  U.S.  and  Italy

 

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
June 21,2020

Bengaluru, Jun 21: As many as 518 private hospitals and medical colleges empanelled under the Suvarna Arogya Suraksha Trust (SAST) have been allowed to treat Covid-19 patients in Karnataka amid rising cases, an official said on Saturday.

"These 518 institutions across the state empanelled under ABArK are permitted to admit and treat Covid patients as per government protocols and criteria," the health official said.

The private hospitals can treat patients only if referred by public authorities such as BBMP Commissioner, Health department Director, District Health Officers and others.

In Bengaluru, there are 44 such empanelled private facilities. The entire list is available at www.arogya.karnataka.gov.in and also on the Health Department's website.

The hospitals will be paid an appropriate package rate for Covid management, said the official.

The state has not barred private hospitals from treating Covid patients but they have to mandatorily report all positive cases.

"Due to increasing number of Covid cases in the state, it was decided to involve private hospitals in treatment of such patients," said Additional Chief Secretary Jawaid Akhtar.

Also Read: These private hospitals in Mangaluru and Udupi can now treat covid patients
 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.